Abbonarsi

Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non–ST-elevation acute coronary syndromes: Observations from the OPUS-TIMI 16 trial - 21/08/11

Doi : 10.1016/j.ahj.2004.05.055 
Warren J. Cantor, MD a, , Shaun G. Goodman, MD a, Christopher P. Cannon, MD b, Sabina A. Murphy, MPH b, Andrew Charlesworth, BSc c, Eugene Braunwauld, MD b, Anatoly Langer, MD a
a Department of Medicine, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada 
b Department of Medicine, Division of Cardiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass 
c Nottingham Clinical Research, Nottingham, UK 

Reprint requests: Warren J. Cantor, MD, Division of Cardiology, St. Michael's Hospital, 30 Bond St, Toronto, Ontario, Canada M5B 1W8.

Supported by the Canadian Heart Research Center.

Riassunto

Background

Early cardiac catheterization has been shown to improve outcomes in patients with non–ST-elevation acute coronary syndromes but not yet in those with ST-elevation myocardial infarction (STEMI). The benefit of catheterization in both syndromes may depend on patient risk for adverse clinical outcomes.

Methods

We analyzed the relation between inhospital catheterization and subsequent clinical outcomes based on risk profile in 8286 patients in the OPUS-TIMI 16 Trial of patients with acute coronary syndromes. Using baseline clinical characteristics, patients were stratified into low-, intermediate-, and high-risk groups. The primary end point was 10-month mortality. The STEMI, non-STEMI (NSTEMI), and unstable angina subgroups were analyzed separately.

Results

Inhospital cardiac catheterization was performed in 44% of patients. Mortality rates at 10 months were 1.3%, 2.2%, and 11.3% in the low-, intermediate-, and high-risk groups, respectively. Inhospital cardiac catheterization was associated with a trend to lower mortality among the high-risk patients with STEMI (hazard ratios [HR] 0.57, 95% CI 0.33-1.01, P = .052) and NSTEMI (HR 0.65, 95% CI 0.39-1.07, P = .088) but not in those with unstable angina (HR 0.95, 95% CI 0.63-1.43, P = .82). Catheterization was not associated with any significant difference in mortality in the low-risk or intermediate-risk group. The differences among high-risk patients persisted after adjusting for baseline characteristics; inhospital catheterization was associated with significantly lower mortality in high-risk patients with ST and non-ST myocardial infarction (HR 0.65, 95% CI 0.45-0.95, P = .03).

Conclusions

Inhospital cardiac catheterization is associated with lower mortality in high-risk patients and no difference in mortality in low-risk and intermediate-risk patients after STEMI and NSTEMI. These data support the hypothesis that high-risk patients with either STEMI or NSTEMI may benefit from an early invasive strategy. New prospective randomized trials are warranted, particularly in the STEMI population.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2005  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 149 - N° 2

P. 275-283 - Febbraio 2005 Ritorno al numero
Articolo precedente Articolo precedente
  • Multimarker risk strategy for predicting 1-month and 1-year major events in non–ST-elevation acute coronary syndromes
  • Vicent Bodí, Juan Sanchis, Àngel Llàcer, Lorenzo Fácila, Julio Núñez, Mauricio Pellicer, Vicente Bertomeu, Vicente Ruiz, Francisco J. Chorro
| Articolo seguente Articolo seguente
  • Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: An open-label randomized pilot study
  • Ezio Faglia, Mantero Manuela, Quarantiello Antonella, Gino Michela, Curci Vincenzo, Caminiti Maurizio, Mattioli Roberto, Morabito Alberto

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.